Pneumonia
Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA New Data on Ceftaroline, a Novel, Broad-Spectrum Ceph
Published in Drug Law Weekly, November 18th, 2008
Forest Laboratories, Inc. (NYSE: FRX) presented a detailed analysis of CANVAS I, a globally conducted, multi-center, Phase III clinical trial, at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy / Infectious Diseases Society of America 46th Annual Meeting (ICAAC / IDSA) in Washington, DC. The results of this 702 patient study demonstrated that ceftaroline monotherapy achieved its primary endpoint of non-inferiority versus the combination of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-11-18)
More Articles from Drug Law Weekly
- 3SBio Inc.
3SBio Inc. Announces Preliminary Third Quarter 2008 Results - Adverse Drug Reactions
New research on adverse drug reactions from Louisiana State University summarized - AmerisourceBergen Corporation
AmerisourceBergen Reports $0.73 Diluted EPS from Continuing Operations, Up 18 Percent, and Revenue Up 5 Percent in the September Quarter - Autism
National Autism Conference to be Held in Weston, FL November 13-16 - Back Pain
Data on back pain discussed by J. Wilsonmacdonald and colleagues - Bergman & Frockt
Bergman & Frockt: Dying Man Fights Forced Autopsy - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
